In recent years, the concept ofSTING pathway targeting therapeutics has generated a lot of enthusiasm withinthe medical science community. The growing popularity of this therapeutictechnique has not only garnered the interest of several medical researchers (reflectedin the increasing volume of scientific literature (1,000+ articles publishedsince 2015) on this subject), but also industry stakeholders focused ondrug development (evident in the growing number of clinical trials and thegrants awarded for STING focused projects in the recent past).
To order this 310+page report, which features 170+ figures and 200+ tables, please visit this link
The USD 2.8 billion(by 2030) financial opportunity within the STING pathway targeting technologiesmarket has been analysed across the following segments:
§ Types of Payment
§ Upfront Payments
§ Milestone Payments
§ Typeof STING Modulator
§ Agonist
§ Antagonist
§ KeyTherapeutic Area(s)
§ OncologicalDisorders
§ InflammatoryDisorders
§ InfectiousDiseases
§ Others
§ Routeof Administration
§ Intratumoral
§ Intravenous
§ Oral
§ Subcutaneous
§ Others
§ Typeof Molecule
§ Non-nucleotide
§ CyclicDinucleotide
§ LiveBiotherapeutics
§ OncolyticPeptides
§ SyntheticPeptides
§ Others
§ KeyGeographical Regions
§ NorthAmerica
§ Europe
§ Asia-Pacific
The STINGPathway Targeting Therapeutics and Technologies, 2020-2030 report features thefollowing companies, which we identified to be key players in this domain:
§ AduroBiotech
§ BristolMyers Squibb
§ Eisai
§ GlaxoSmithKline
§ ImmuneSensorTherapeutics
§ Merck
§ Noxopharm
§ SpringBank Pharmaceuticals
§ Synlogic
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. STING Pathway TargetingTherapeutics: Current Market Landscape
5. STING Pathway TargetingTechnologies: Current Market landscape
6. Company Profiles
7. Academic Grant Analysis
8. STING Related Initiatives ofBig Pharmaceutical Players
9. Start-up Health Indexing
10. Publication Analysis
11. Partnerships andCollaborations
12. Funding and InvestmentAnalysis
13. Market Sizing andOpportunity Analysis
14. Executive Insights
15. Concluding Remarks
16. Appendix 1: Tabulated Data
17. Appendix 2: List ofCompanies and Organizations
To purchase a copy,please visit https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
